Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey

Creative Commons License

BORU U., ALP R., SARGIN H., KOCER A., Sargin M., LULECI A., ...More

ENDOCRINE JOURNAL, vol.51, no.6, pp.563-567, 2004 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 6
  • Publication Date: 2004
  • Doi Number: 10.1507/endocrj.51.563
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.563-567


The aim of this study was to determine the prevalence and risk factors for neuropathy in type 2 diabetic patients attending a major Turkish diabetes center. Eight hundred and sixty-six consecutive type 2 diabetic patients were included in the study. A single observer performed biothesiometry studies on these patients. The presence of diabetic neuropathy was investigated using neurological symptom scale (NSS) and neurological disability score (NDS) performed. Neuropathy was determined with standardized neurological examinations and defined as the presence of abnormal NSS and NDS together with abnormal sensory or motor signs and symptoms as well as decreased great toe vibration perception. Overall, 60% (n = 520) of the patients were diagnosed as having neuropathy. The prevalence of neuropathy increased with age (p<0.001) and duration of diabetes (p<0.001). Multiple logistic regression analysis revealed the duration of diabetes (p<0.001)and HbA1c levels (p<0.001) asthe risk factors for neuropathy. The overall prevalence of neuropathy in Turkish type 2 diabetic population was 60%. Age, duration of diabetes, and poor glycemic control were considered to be the risk factors for neuropathy.